Sugi Predict

Sugi Predict / Compounds / SCHEMBL29835305

SCHEMBL29835305

SCHEMBL29835305

CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ TFPI P10646 1/20 0.61
▸ KISS1R Q969F8 15/20 0.61
▸ OPRD1 P41143 1/20 0.57
▸ VIPR1 P32241 1/20 0.56
▸ NPY4R P50391 3/20 0.56
▸ NPY1R P25929 2/20 0.56
▸ NPY2R P49146 2/20 0.56
▸ NPY5R Q15761 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29835241 0.96 NPY4R (0.61) TFPIKISS1RNPY4RNPY1RNPY2R
SCHEMBL30924757 0.95 NPY4R (0.58) TFPIKISS1RNPY4RNPY1RNPY2R
SCHEMBL30924735 0.91 TFPI (0.59) TFPIKISS1RVIPR1NPY4RNPY1R
SCHEMBL30924753 0.91 NPY4R (0.57) TFPIKISS1RNPY4RNPY1RNPY2R
SCHEMBL31430947 0.91 KISS1R (0.60) TFPIKISS1RVIPR1
SCHEMBL29434670 0.90 NPY4R (0.65) KISS1RNPY4RNPY1RNPY2RNPY5R
SCHEMBL31047374 0.90 TFPI (0.66) TFPIKISS1RVIPR1
SCHEMBL30924746 0.90 TFPI (0.59) TFPIKISS1RNPY4RNPY1RNPY2R
SCHEMBL30924750 0.90 TFPI (0.60) TFPIKISS1RVIPR1NPY4RNPY1R
SCHEMBL30612278 0.90 NPY4R (0.59) KISS1RVIPR1NPY4RNPY1RNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4313100-A2 PEPTIDES AND METHODS FOR REDUCING SKIN PIGMENTATION GLO Pharma, Inc. (US) 2024-02-07 — — EP disclosed
WO-2022204305-A2 PEPTIDES AND METHODS FOR REDUCING SKIN PIGMENTATION GLO PHARMA, INC. (US) 2022-09-29 — — WO disclosed
Send feedback